Continuing Education  » Internal Medicine - Small Animal  » Emerging Therapies for Diabetes Mellitus & Obesity? An ACVIM 2016 Endocrine Disease Up...

Emerging Therapies for Diabetes Mellitus & Obesity? An ACVIM 2016 Endocrine Disease Update

CE Event Information

  • Description:
    A recap of news you can use from the 2016 ACVIM Forum. The focus of this segment is on an emerging therapy for cats with diabetes mellitus and, possibly, obesity - specifically incretin-based therapies. Read more:

    Discussion includes:

    - Incretins: What they are and their biologic effects
    - Applications of incretin-based therapy including treatment of diabetes mellitus and obesity
    - Findings of pilot studies examining the effects of incretin-based therapies in cats including: Byetta®, Bydureon®, Victoza®, and a DPP-4 Inhibitor

    Running time: 8 minutes

    Member Fee: $14.95; Free registration for new Members, Unlimited Plus members, and Evidence Based Update subscribers
  • Sponsor: VetVine Specialty Consulting Service
  • Presenter(s): Elisabeth Zenger, DVM, PhD, DACVIM (SAIM)
  • Fee (Basic Membership): $14.95

Featured Publications

The following journal articles or textbook chapters have been selected as Supplements to this event. You can elect to purchase them as part of a discounted seminar package fee.
Prepaid CE Subscribers will be assessed a supplement fee for articles purchased.

  • Feline Diabetes Mellitus and Diabetic Ketoacidosis Package

    This package includes 3 textbook Chapters published in 2015 (total of 94 pages) - details below. Member Fee: $19.95; Login to purchase and d...  more
  • Diabetes Mellitus

    Canine and Feline Nutrition (Third Edition), 2011; Chapter 29, pp 343-358. Authors: Linda P. Case, Leighann Daristotle, Michael G. Hayek, Me...  more